The potential of generative AI with prostate-specific membrane antigen (PSMA) PET/CT: challenges and future directions
The diagnosis and prognosis of Prostate cancer (PCa) have undergone a significant transformation with the advent of prostate-specific membrane antigen (PSMA)-targeted positron emission tomography (PET) imaging. PSMA-PET imaging has demonstrated superior performance compared to conventional imaging m...
Saved in:
| Main Authors: | Islam Md Zobaer, Spiro Ergi, Yap Pew-Thian, Gorin Michael A., Rowe Steven P. |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
De Gruyter
2025-01-01
|
| Series: | Medical Review |
| Subjects: | |
| Online Access: | https://doi.org/10.1515/mr-2024-0086 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Updates on controversies surrounding the staging and management of newly diagnosed localized prostate cancer using prostate-specific membrane antigen (PSMA) positron emission tomography
by: Patricia Tai, et al.
Published: (2025-07-01) -
Cinematic rendering of 18F‐DCFPyL PET/CT fusion data in a patient with metastatic clear cell renal cell carcinoma
by: Steven P. Rowe, et al.
Published: (2024-06-01) -
Detection Rates of PSMA-PET Radiopharmaceuticals in Recurrent Prostate Cancer: A Systematic Review
by: Soroush Rais-Bahrami, et al.
Published: (2025-05-01) -
68Ga-PSMA PET/CT versus CT and bone scan for investigation of PSA failure post radical prostatectomy
by: Yuigi Yuminaga, et al.
Published: (2021-04-01) -
The Performance and Role of PSMA PET Scans in Localised Prostate Cancer
by: Jianliang Liu, et al.
Published: (2025-02-01)